This program will complete research and development, and launch implementation and commercialization of a technology for differential diagnosis of infectious diseases that integrates PCR and atmospheric pressure chemical ionization mass spectroscopy (MS) into a stable and sensitive digital assay platform with the advantages of simultaneous detection and discrimination of multiple targets. This platform, Mass Tag PCR will first be used to distinguish pathogens implicated in acute, severe respiratory disease including SARS CoV and influenza viruses, and later extended to other NIAID priority agents. Features that will enhance the probability of success include: expertise of applicants in clinical microbiology, bioinformatics, and molecular diagnostics; a novel technology for mass spectrometric detection of PCR amplification products; banks of viral primer sequences, cDNA targets and mass tags; access to miniaturized mass spectrometric instruments suited to field applications; partnership in an international surveillance network wherein clinical samples can be shared for assay optimization and validation, and a commercial network for quality controlled manufacture and global distribution of reagents for molecular biology.
Aim 1 : Establish multiplex PCR/MS assay on conventional MS instruments for detection of respiratory pathogens that cause severe pneumonia;
Aim 2 : Build portable APCI MS instruments to support multiplex PCR/MS platform;
Aim 3 : Transfer multiplex assays from conventional to portable APCI MS instruments;
Aim 4 : Establish PCR/MS technology at network laboratories;
Aim 5 : Transfer technology to detection of NIAID Category A, B, and C priority agents.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
NIH Challenge Grants and Partnerships Program - Phase II-Coop.Agreement (UC1)
Project #
Application #
Study Section
Special Emphasis Panel (ZAI1-TH-M (M1))
Program Officer
Salomon, Rachelle
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
Public Health & Prev Medicine
Schools of Public Health
New York
United States
Zip Code
Collao, Ximena; Palacios, Gustavo; Sanbonmatsu-Gamez, Sara et al. (2009) Genetic diversity of Toscana virus. Emerg Infect Dis 15:574-7
Honkavuori, Kirsi S; Shivaprasad, H L; Williams, Brent L et al. (2008) Novel borna virus in psittacine birds with proventricular dilatation disease. Emerg Infect Dis 14:1883-6
Briese, Thomas; Renwick, Neil; Venter, Marietjie et al. (2008) Global distribution of novel rhinovirus genotype. Emerg Infect Dis 14:944-7
Palacios, Gustavo; Druce, Julian; Du, Lei et al. (2008) A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 358:991-8
Renwick, Neil; Schweiger, Brunhilde; Kapoor, Vishal et al. (2007) A recently identified rhinovirus genotype is associated with severe respiratory-tract infection in children in Germany. J Infect Dis 196:1754-60
Briese, T; Kapoor, V; Lipkin, W I (2007) Natural M-segment reassortment in Potosi and Main Drain viruses: implications for the evolution of orthobunyaviruses. Arch Virol 152:2237-47
Quan, Phenix-Lan; Palacios, Gustavo; Jabado, Omar J et al. (2007) Detection of respiratory viruses and subtype identification of influenza A viruses by GreeneChipResp oligonucleotide microarray. J Clin Microbiol 45:2359-64
Lamson, Daryl; Renwick, Neil; Kapoor, Vishal et al. (2006) MassTag polymerase-chain-reaction detection of respiratory pathogens, including a new rhinovirus genotype, that caused influenza-like illness in New York State during 2004-2005. J Infect Dis 194:1398-402
Jabado, Omar J; Palacios, Gustavo; Kapoor, Vishal et al. (2006) Greene SCPrimer: a rapid comprehensive tool for designing degenerate primers from multiple sequence alignments. Nucleic Acids Res 34:6605-11